PDXK and pancreatic neoplasm: The experimental process involved implanting an MP2 stem-like pancreatic tumor in hu-BLT mice, followed by administering PKH-labeled sNK cells to evaluate their distribution in the peripheral blood, bone marrow, and spleen of hu-BLT mice.